Robert A. Hegele
Blackburn Cardiovascular Genetics Laboratory
Robarts Research Institute
University of Western Ontario
London
Canada
Name/email consistency: high
- Advances in stroke 2009: update on the genetics of stroke and cerebrovascular disease 2009. Hegele, R.A., Dichgans, M. Stroke (2010)
- Rare ATGL haplotypes are associated with increased plasma triglyceride concentrations in the Greenland Inuit. Johansen, C.T., Gallinger, Z.R., Wang, J., Ban, M.R., Young, T.K., Bjerregaard, P., Hegele, R.A. Int. J. Circumpolar. Health (2010)
- Hoofbeats, zebras, and insights into insulin resistance. Hegele, R.A., Reue, K. J. Clin. Invest. (2009)
- A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia. Hegele, R.A., Ban, M.R., Hsueh, N., Kennedy, B.A., Cao, H., Zou, G.Y., Anand, S., Yusuf, S., Huff, M.W., Wang, J. Hum. Mol. Genet. (2009)
- Hypertriglyceridemia: phenomics and genomics. Hegele, R.A., Pollex, R.L. Mol. Cell. Biochem. (2009)
- Plasma lipoproteins: genetic influences and clinical implications. Hegele, R.A. Nat. Rev. Genet. (2009)
- Update on the genetics of stroke and cerebrovascular disease 2007. Hegele, R.A., Dichgans, M. Stroke (2008)
- Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism. Hegele, R.A., Joy, T.R., Al-Attar, S.A., Rutt, B.K. J. Lipid Res. (2007)
- Phenomics and lamins: from disease to therapy. Hegele, R.A., Oshima, J. Exp. Cell Res. (2007)
- Genetic susceptibility to heart disease in Canada: lessons from patients with familial hypercholesterolemia. Hegele, R.A. Genome (2006)
- Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy. Hegele, R.A., Cao, H., Liu, D.M., Costain, G.A., Charlton-Menys, V., Rodger, N.W., Durrington, P.N. Am. J. Hum. Genet. (2006)
- Lessons from human mutations in PPARgamma. Hegele, R.A. Int. J. Obes. (Lond) (2005)
- ABC transporters and sterol absorption. Hegele, R.A., Robinson, J.F. Curr. Drug. Targets. Cardiovasc. Haematol. Disord (2005)
- Genetic and physiological insights into the metabolic syndrome. Hegele, R.A., Pollex, R.L. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2005)
- LMNA mutation position predicts organ system involvement in laminopathies. Hegele, R. Clin. Genet. (2005)
- NPC1L1 haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibe. Hegele, R.A., Guy, J., Ban, M.R., Wang, J. Lipids. Health. Dis (2005)
- Disparate associations of a functional promoter polymorphism in PCK1 with carotid wall ultrasound traits. Hegele, R.A., Al-Shali, K.Z., House, A.A., Hanley, A.J., Harris, S.B., Mamakeesick, M., Fenster, A., Zinman, B., Cao, H., Spence, J.D. Stroke (2005)
- Phenomics, lipodystrophy, and the metabolic syndrome. Hegele, R.A. Trends Cardiovasc. Med. (2004)
- Unbuckling lipodystrophy from insulin resistance and hypertension. Hegele, R.A., Leff, T. J. Clin. Invest. (2004)
- DNA polymorphism and mutations in CPN1, including the genomic basis of carboxypeptidase N deficiency. Cao, H., Hegele, R.A. J. Hum. Genet. (2003)
- Genes, environment and Oji-Cree type 2 diabetes. Hegele, R.A., Zinman, B., Hanley, A.J., Harris, S.B., Barrett, P.H., Cao, H. Clin. Biochem. (2003)
- Drawing the line in progeria syndromes. Hegele, R.A. Lancet (2003)
- Monogenic forms of insulin resistance: apertures that expose the common metabolic syndrome. Hegele, R.A. Trends Endocrinol. Metab. (2003)
- PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. Hegele, R.A., Cao, H., Frankowski, C., Mathews, S.T., Leff, T. Diabetes (2002)